相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
CD340 (erbB2/HER-2)
- 级别:
CD340 (erbB2/HER-2) Antibody
- 目录编号:
CD340 (erbB2/HER-2) Antibody
- 克隆性:
单克隆
- 抗原来源:
小鼠
- 保质期:
CD340 (erbB2/HER-2) Antibody
- 抗体英文名:
anti-human CD340 (erbB2/HER-2) Antibody-PE
- 抗体名:
CD340 (erbB2/HER-2) Antibody
- 标记物:
PE
- 宿主:
小鼠
- 适应物种:
人
- 免疫原:
CD340 (erbB2/HER-2) Antibody
- 亚型:
CD340 (erbB2/HER-2) Antibody
- 形态:
CD340 (erbB2/HER-2) Antibody
- 应用范围:
FC
- 保存条件:
2-8℃
- 浓度:
CD340 (erbB2/HER-2) Antibody
- 规格:
25 tests/100 tests
| 规格: | 25 tests | 产品价格: | ¥2200.0 |
|---|---|---|---|
| 规格: | 100 tests | 产品价格: | ¥4800.0 |
Description :CD340 is also known as HER2/erbB2, tyrosine kinase cell surface receptor HER2, oncogeneERBB2, and oncogene NGL, neuroblastoma- or glioblastoma-derived. It is a member of theepidermal growth factor receptor family of cell membrane tyrosine kinases containing a singletransmembrane domain and has an approximate molecular weight of 185 kD. CD340 containsthree furin repeats and two cheY homologous receiver domains in the extracellular region(ECR). The HER2/erbB2 protein is expressed on many tumor cells, including some breastcancers, lung adenocarcinoma, gastric cancer, ovarian cancer, gliblastoma, some c-ALL blastsand bone marrow mesenchymal stem cells. Although the erbB2/HER2 protein contains noligand binding domain, this protein interacts with other EGF receptor family members to form aheterodimer, stabilize ligand binding, and enhance kinase-mediated downstream signaling.CD340 has been shown to be involved in embryonic development and cancer progression; thisprotein is amplified in adenocarcinoma of the lung, some breast cancers, glioblastoma, gastriccancer, and ovarian carcinoma, where it functions as an oncogene. Overexpression of erbB2in breast cancers has been shown to confer Taxol resistance and is a therapeutic target in anumber of human cancers. The erbB2/HER-2 protein has been shown to interact with a largenumber of proteins, including SHC1, EGF receptorm, neuroregulin 1, c-Src, integrin β4, Grb2,Grb7, SOS1, caveolin 1, JAK2, PAK1, FAK, and β-catenin, among others. CD340 is extensivelymodified by tyrosine phosphorylation on multiple residues (Y1023, Y1139, Y1196, Y1221,Y1222, Y1248).
Verified Reactivity :Human
Antibody Type :Monoclonal
Host Species :Mouse
Immunogen :NIH-3T3 transfected with human HER-2
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation :The antibody was purified by affinity chromatography, and conjugated with PE under optimalconditions.
Concentration :Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser :Blue Laser (488 nm)、Green Laser (532 nm)、Yellow-Green Laser (561 nm)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验1. Bühring HJ, et al. 1995. Blood 86:1916.
Product Citations:
1. Zhang C, et al. 2015. J Natl Cancer Inst. 108: djv375. PubMed
2. Lange T, et al. 2011. Cancer Lett. 308:54. PubMed
3. Kazemi S, et al. 2020. Biochem Pharmacol. 114317:183. PubMed
4. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
5. Miller IC, et al. 2021. Nature Biomedical Engineering. :. PubMed
6. Vishnoi M, et al. 2015. Sci Rep. 5: 17533. PubMed
7. Skidmore L, et al. 2020. Mol Cancer Ther. 19:1833. PubMed
8. Pahuja KB et al. 2018. Cancer cell. 34(5):792-806 . PubMed
9. Baldassarre T, Truesdell P, and Craig A. 2017. Breast Cancer Res.. 10.1186/s13058-017-0900-z. PubMed
10. Castagnoli L, et al. 2016. Oncogene. 10.1038/onc.2016.338. PubMed
11. MESCHENMOSER K, et al. 2013. In Vivo. 27:431. PubMed
12. Li Z, et al. 2010. J Virol Methods. 169:87. PubMed
流式课堂 | 易被忽略的 CD4、CD8 共表达细胞——胸腺淋巴细胞
做过流式实验的同学,对 CD4、CD8 这两个指标都不会陌生。检测 CD4+ T 细胞和 CD8+ T 细胞分型,是流式中最常见的实验之一。 通常,我们会先检测 CD3,来圈总T淋巴细胞,再分别用 CD4 抗体和 CD8 抗体,来区分 CD4+ T 淋巴细胞(辅助或调节性T细胞)和 CD8+ T 淋巴细胞(细胞毒性 T 细胞)。 新生小鼠脾脏细胞 上图为新生小鼠脾脏细胞进行的 CD3-PE、CD4-FITC、CD8-APC 三色流式实验结果。从图中可以看出,在新生小鼠脾脏中,绝大
- 3) 及 CD45 -PE (HI30,白细胞标志) 抗体染色后,进行流式分析,死细胞以 DAPI 染色先行排除,左右分别为分选前后的细胞群分布。 总结: 几次实验的结果,使用 Fab-TACS® Gravity column 来从全血直接进行 CD3+ T 细胞分选,平均得率为 84.5%,纯度大于 90%,细胞存活率高于 95%,且目标细胞不含标记,贴近天然,使下游实验更精确。
--人淋巴细胞分离液(科研))图 2:使用达优人淋巴细胞分离液分离 PBMC 结果(2)阴选试剂盒,分选之后,倾倒的液体为目的细胞,弃置细胞与磁珠相连,被均匀的吸附于管壁上。图 3:试管置于磁极中及分选后被磁珠标记的细胞(3)分离出 PBMC 之后计数,采用 cellometer Mini 计数,预留部分细胞作为分选前的对照。按照说明书分别加入相应量的抗体及磁珠, 进行分选实验,分选后流式分析细胞纯度并计算细胞得率。图 4:阴选流程(免洗步骤)(4)结果分选前标记 CD4 :PE-CD










